Business
Cipher Announces Change to Board of Directors
Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON , Dec. 30, 2013 /CNW/ - Cipher ...
About this update from Cipher Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\nToronto Stock Exchange Symbol: DND\n\n\nMISSISSAUGA, ON, Dec. 30, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:\n DND) (\"Cipher\" or \"the Company\") today announced that William (Bill)\n Garriock has resigned from his position of Chair of Cipher, effective\n December 31, 2013, as he is retiring from active business. Cipher's\n Board expects to appoint a new Chair in the near future.\n\n\n\"On behalf of the Board, I would like to thank Bill for his service and\n contributions and wish him well in retirement,\" said Larry Andrews, CEO\n and Director of Cipher.\n\n\nAbout Cipher Pharmaceuticals Inc.\n\n\nCipher Pharmaceuticals (TSX: DND) is a growing specialty pharmaceutical\n company with three commercial products and a fourth in development. Our\n product candidates are typically improved formulations of successful,\n currently marketed drugs. We in-license a product, manage the required\n clinical development and regulatory approval process, and either\n out-license it to a marketing partner, or, in Canada, we may market the\n product ourselves. Our core capabilities are in clinical and regulatory\n affairs, product licensing, supply chain management, and marketing and\n sales. Since the Company was founded in 2000, we have achieved final\n regulatory approval in the U.S. and Canada for all three of our\n original products and completed six marketing partnerships, generating\n growing licensing revenue.\n\n\nSOURCE Cipher Pharmaceuticals Inc.\n\n\n\n Craig Armitage Investor Relations TMX Equicom (416) 815-0700 ext 278 (416) 815-0080 fax [email protected] Larry Andrews President and CEO Cipher Pharmaceuticals (905) 602-5840 ext 324 (905) 602-0628 fax  [email protected] Copyright CNW Group 2013","length":2512,"tagName":"div"}]